Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder
出版年份 2022 全文链接
标题
Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume 15, Issue 2, Pages 175-185
出版商
Informa UK Limited
发表日期
2022-03-14
DOI
10.1080/17512433.2022.2053520
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder
- (2021) Sébastien Lalanne et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders
- (2021) Carmen M. Schroder et al. EXPERT OPINION ON PHARMACOTHERAPY
- Sleep, Growth, and Puberty After Two Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder
- (2020) Beth A. Malow et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder
- (2020) Ashura Williams Buckley et al. NEUROLOGY
- Systematic Review of Sleep Disturbances and Circadian Sleep Desynchronization in Autism Spectrum Disorder: Toward an Integrative Model of a Self-Reinforcing Loop
- (2019) Claudia Carmassi et al. Frontiers in Psychiatry
- New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation
- (2018) Nava Zisapel BRITISH JOURNAL OF PHARMACOLOGY
- Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder
- (2018) Athanasios Maras et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review
- (2018) Bryony Beresford et al. HEALTH TECHNOLOGY ASSESSMENT
- Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content
- (2017) Lauren A.E. Erland et al. Journal of Clinical Sleep Medicine
- Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder
- (2017) Paul Gringras et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Effectiveness of Sleep-Based Interventions for Children with Autism Spectrum Disorder: A Meta-Synthesis
- (2017) Belinda M. Cuomo et al. PHARMACOTHERAPY
- Sleep in Children with Autism Spectrum Disorder
- (2017) Margaret C. Souders et al. Current Psychiatry Reports
- Quality control and determination of melatonin in food supplements
- (2016) Ana B. Cerezo et al. JOURNAL OF FOOD COMPOSITION AND ANALYSIS
- CSF generation by pineal gland results in a robust melatonin circadian rhythm in the third ventricle as an unique light/dark signal
- (2016) Dun-Xian Tan et al. MEDICAL HYPOTHESES
- Pharmacokinetics of oral and intravenous melatonin in healthy volunteers
- (2016) Lars P. H. Andersen et al. BMC Pharmacology & Toxicology
- Dissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of Melatonin
- (2016) Hui Chua et al. Pharmaceutics
- Insomnia, Health-Related Quality of Life and Health Outcomes in Children: A Seven Year Longitudinal Cohort
- (2016) Daniel Combs et al. Scientific Reports
- The use of melatonin in Swedish children and adolescents—a register-based study according to age, gender, and medication of ADHD
- (2015) Catrin Furster et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Current role of melatonin in pediatric neurology: Clinical recommendations
- (2015) Oliviero Bruni et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- High membrane permeability for melatonin
- (2015) Haijie Yu et al. JOURNAL OF GENERAL PHYSIOLOGY
- The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
- (2014) RE Appleton et al. HEALTH TECHNOLOGY ASSESSMENT
- Potential drug interactions with melatonin
- (2014) Eleni Papagiannidou et al. PHYSIOLOGY & BEHAVIOR
- Melatonin for sleep disorders in children
- (2014) Julia Kuczynska European Journal of Hospital Pharmacy-Science and Practice
- Advances in the Research of Melatonin in Autism Spectrum Disorders: Literature Review and New Perspectives
- (2013) Sylvie Tordjman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial
- (2012) FLAVIA CORTESI et al. JOURNAL OF SLEEP RESEARCH
- A Practice Pathway for the Identification, Evaluation, and Management of Insomnia in Children and Adolescents With Autism Spectrum Disorders
- (2012) Beth A. Malow et al. PEDIATRICS
- Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial
- (2012) P. Gringras et al. BMJ-British Medical Journal
- Melatonin in autism spectrum disorders: a systematic review and meta-analysis
- (2011) DANIEL A ROSSIGNOL et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Prolonged-Release Melatonin for Children With Neurodevelopmental Disorders
- (2011) Hélène De Leersnyder et al. PEDIATRIC NEUROLOGY
- A Model-Based Approach to Dose Selection in Early Pediatric Development
- (2010) M Cella et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- THE TREATMENT OF SLEEP DISORDERS WITH MELATONIN
- (2010) J. E. Jan et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers
- (2008) S. Otmani et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Melatonin for Insomnia in Children With Autism Spectrum Disorders
- (2008) Ivy M. Andersen et al. JOURNAL OF CHILD NEUROLOGY
- Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
- (2008) Arzu Gunes et al. PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started